Examining the relationship of smoking habits, respiratory symptoms and lung function to mortality in men from the general population aged 50--60 years, Olofson et al. ([@CIT0001]) demonstrated that the mortality rate was significantly related to age, smoking habits, and dyspnea. Furthermore, these authors showed that impaired lung function is an important factor to be considered in the assessment of mortality risk, besides smoking and dyspnea.

Smoking is one of the most important risk factors for future cardiovascular morbidity and a major cause of cardiovascular disease mortality ([@CIT0002]). It has significant detrimental effects on both the structure and function of the lung; it is the single most important risk factor for the development of chronic obstructive pulmonary disease (COPD) ([@CIT0003]). Studies have documented lower forced expiratory volume in 1 second (FEV~1~), accelerated loss of ventilatory function, and increased respiratory symptoms among smokers compared with non-smokers ([@CIT0004]). Data from other studies have consistently shown increased mortality from COPD, and pneumonia among cigarette smokers compared with non-smokers ([@CIT0005]). Smokers had double the mortality rate of non-smokers ([@CIT0001]). According to Higgins et al., the prevalence of chronic bronchitis was higher and mean FEV~1~ was lower in cigarette smokers than non-smokers, and heavy smokers were affected more than light smokers ([@CIT0006]). Likewise, the results reported by Mohammad et al. showed a higher proportion of chronic bronchitis and a quasi-permanent alteration in maximum mid-expiratory flow (MMEF 25--75%) in narguileh smokers compared with cigarette smokers. These authors added that FEV1 was more altered in cigarette smokers than in narguileh smokers ([@CIT0007]).

Physical training can enhance health in many ways. It has been shown to improve cardiovascular performance ([@CIT0008], [@CIT0009]), to prevent premature death ([@CIT0010]), and to promote longevity ([@CIT0011], [@CIT0012]). In previous studies, regular exercise training has been related to better pulmonary function ([@CIT0013], [@CIT0014]). Also other studies report a positive association between physical activity and physical fitness and lung capacity ([@CIT0015], [@CIT0016]), while others do not ([@CIT0017]).

The $\overset{.}{\text{V}}\text{O}_{2}\text{max}$ components, heart rate (HR) and systolic blood pressure (SBP), are important indicators of cardiovascular health and fitness. Lower HR at rest and during exercise is associated with improved physical fitness ([@CIT0018]--[@CIT0020]). Higher values of HR and SBP at rest, as well as their increased variability and response during exercise, are important risk factors and prognostic indicators of cardiovascular disease mortality ([@CIT0021], [@CIT0022]). Smokers usually exhibit elevated HR and reduced exercise capacity and, thus, lower overall cardiovascular fitness ([@CIT0023], [@CIT0024]).

The benefit of training programs appears to be important in the general healthy population for increasing cardiorespiratory performance ([@CIT0025]). The practice of physical activity is associated with an increase in $\overset{.}{\text{V}}\text{O}_{2}\text{max}$ regardless of age ([@CIT0026], [@CIT0027]). Moreover, several studies examining the effects of physical training on BP, HR, and $\overset{.}{\text{V}}\text{O}_{2}\text{max}$ in healthy adults have yielded convincing results ([@CIT0012], [@CIT0028], [@CIT0029]).

Most studies on the effects of physical activity on respiratory and cardiovascular functions focused on special populations, such as athletes or patients with COPD ([@CIT0030], [@CIT0031]). However, it is not known whether intermittent physical training can retard the deterioration of pulmonary function and improve cardiorespiratory fitness in smokers unwilling or unable to quit.

Investigating the relationship between physical activity and cardiovascular and respiratory functions of smokers will aid in understanding the mechanisms of how physical activity improves quality of life. The major purpose of this study was to examine the effects of 12 weeks of intermittent training on pulmonary function among sedentary cigarette smokers versus hookah smokers. We also evaluated how physical activity affects exercise tolerance of the participants.

Methods {#S0002}
=======

Participants {#S0002-S20001}
------------

A total of 35 sedentary smokers and non-smokers with the following average characteristics±standard deviation (SD) participated in this study: age, 44.7±4.5 years; weight, 71.3±2.7 kg; height, 174.3±2.3 cm.

After receiving a complete verbal description of protocol, risks and benefits of the study, each subject signed a written consent. This study was approved by the Faculty of Medicine Ethical Research Committee, University of Sfax, Tunisia.

We excluded people who had any self-reported physician-diagnosed chronic disease (arthritis, diabetes, hypertension, cancer, heart attack, chronic cough, bronchitis, abnormal exercise electrocardiogram, or FEV~1~/FVC%\<70%) ([@CIT0032], [@CIT0033]) at the visit before protocol.

Cigarette and hookah smokers unable or unwilling to quit were recruited according to the number of cigarettes and hookahs per day and how long they have been smoking. We considered cigarette smokers all subjects with consumption greater or equal to 10 pack-years (PY) and an average score of tobacco dependence of 7.33±1.67, measured by the Fagerström nicotine dependence test ([@CIT0034]). In the absence of specific international codification, we quantified hookah consumption, as in the study of Kiter et al. ([@CIT0035]), in hookah-years (HY) and kilogram of cumulative tobacco. The tobacco used in a single hookah session weighs between 10 and 25 g ([@CIT0036]). Regular hookah smokers are those having tobacco consumption greater or equal to 5 HY ([@CIT0037]).

Participants were divided into three groups: a cigarette smoker group (CS) (*n*=11), a hookah smoker group (HS) (*n*=12), and a non-smoker group (NS) (*n*=12).

Pulmonary function assessment {#S0002-S20002}
-----------------------------

Spirometry assessments were undertaken in accordance with standards described by the American Thoracic Society ([@CIT0038]). Standard procedure requires forced vital capacity (FVC) and FEV~1~ to be measured from a series of at least three forced expiratory curves ([@CIT0039]). Consequently, this study required participants to perform three correct manoeuvres. Participants completed the spirometry assessment seated, using a portable spirometer (MIR Spirobank G USB Spirometer, Rome, Italy), with a nose clip attached. Pulmonary function variables included FVC, FEV~1~, and FEV~1~/FVC ratio. Results were expressed as percentages of the predicted value to allow comparison of results across participants.

Aerobic capacity assessment {#S0002-S20003}
---------------------------

Exercise tolerance, achieved during a maximal treadmill exercise test, is a leading indicator of circulatory system capacity as it is strongly related to maximum oxygen uptake ($\overset{.}{\text{V}}\text{O}_{2}\text{max}$) ([@CIT0040]). All the participants underwent a progressive exercise test performed on a treadmill (Pulmonary Function Equipment, COSMED, Rome, Italy) in the research unit of the Higher Institute of Sport and Physical Education of Sfax. The test began with a warm-up at a speed of 6 km/h for 5 min, after which the speed was increased incrementally by 1 km/h every 2 min until exhaustion. HR was monitored throughout the test using Polar Electro Oy (Kempele, Finland) and was recorded at the conclusion of every 2-min stage. Verbal encouragement was provided throughout the test to ensure that the maximal effort was achieved. During the exercise test, oxygen consumption was continually recorded using an oxygen analyzer (Fitmate, version 1.2 PRO COSMED). Oxygen consumption (VO~2~) during the exercise test was measured in real time by means of a dynamic mixing chamber, and data were recorded every 2 min. At the end of the test, a detailed report was printed.

Exercise program {#S0002-S20004}
----------------

All training sessions were completed at the Higher Institute of Sport and Physical Education of Sfax under supervision of qualified specialist trainers. Subjects in the three groups underwent an intermittent training program that consisted of three sessions per week for approximately 30 min per session, during a 12-week period. The intensity of the exercise was controlled by time and distance travelled. All warm-ups before training were between 50 and 60% of maximum HR for a period of about 10 min.

The intermittent training consisted of 30 min of work/rest. Participants were instructed to run for 2 min at an intensity workload that equated to 70% of their individual v $\overset{.}{\text{V}}\text{O}_{2}\text{max}$, interspersed with recovery periods of 1 min. This sequence was repeated 10 times during the 30-min period. Exercise intensity was gradually increased every 2 weeks over the course of the training period, based on the ability of each participant.

Statistical analysis {#S0002-S20005}
--------------------

All statistical tests were processed using STATISTICA Software (StatSoft, France). The data are expressed as mean±SD. Analysis of variance (ANOVA) was carried out to compare the responses of the different groups before and after the training program. Least significant difference (LSD) post-hoc analysis was used to identify significant group differences that were indicated by ANOVA. A probability level of 0.05 was selected as the criterion for statistical significance.

Results {#S0003}
=======

Before training, we did not observe any significant difference in basal cardiorespiratory values between the non-smoker group and the smoker groups. The (Δ) results of the maximal exercise tests after training are presented in [Table 1](#T0001){ref-type="table"}. At the end of the training program, the participants showed similar improvements. However, no significant differences were found among the three groups. After the training program, a small but significant decrease (*p*\<0.05) in the resting HR was observed in each of the three groups (3±4, 3±3, and 2±4 for NS, CS, and HS, respectively). Similarly, there was a decrease of 2±3 (mm Hg) in systolic BP for each of the three groups. The decrease in the diastolic BP was significant only in the CS group.

###### 

Improvement rate (Δ) of cardio-respiratory values in subjects of the three groups (NS, CS, and HS)

  Parameters                                                      Mean±SD   Pre vs. Post                                                                                       
  --------------------------------------------------------------- --------- -------------- --------- ------------------------------------ ------------------------------------ -----------------------------------
  Resting HR (bpm)                                                −3±4      −3±3           −2±4      [†](#TF0001){ref-type="table-fn"}    [†](#TF0001){ref-type="table-fn"}    [†](#TF0001){ref-type="table-fn"}
  Systolic BP (mm Hg)                                             −2±3      −2±3           −2±2      [†](#TF0001){ref-type="table-fn"}    [††](#TF0001){ref-type="table-fn"}   [†](#TF0001){ref-type="table-fn"}
  Diastolic BP (mm Hg)                                            −2±4      −3±5           −2±3      ns                                   [†](#TF0001){ref-type="table-fn"}    ns
  v $\overset{.}{\text{V}}\text{O}_{2}\text{max}$ (km/h)          0.7±1     0.6±0.9        0.4±0.6   [††](#TF0001){ref-type="table-fn"}   [†](#TF0001){ref-type="table-fn"}    ns
  $\overset{.}{\text{V}}\text{O}_{2}\text{max}$ (ml·min·kg^−1^)   1.7±3.3   1.8±2.6        1.5±2.1   [†](#TF0001){ref-type="table-fn"}    [†](#TF0001){ref-type="table-fn"}    ns
  Recovery index                                                  1.2±1.3   1.6±2.5        0.9±1.5   [†](#TF0001){ref-type="table-fn"}    [††](#TF0001){ref-type="table-fn"}   ns

NS: non-smokers; CS: cigarettes smokers; HS: hookah smokers; $\overset{.}{\text{V}}\text{O}_{2}\text{max}$: maximum oxygen uptake; v $\overset{.}{\text{V}}\text{O}_{2}\text{max}$: velocity at maximum oxygen uptake; HR: heart rate; bpm: beats per minute; BP: blood pressure.

significant difference Pre- vs. Post program at *p*\<0.05, *p*\<0.01, respectively.

At maximal exercise, there was an increase of 6.7 and 5.6% in v $\overset{.}{\text{V}}\text{O}_{2}\text{max}$, an increase of 4.4 and 4.7% in $\overset{.}{\text{V}}\text{O}_{2}\text{max}$, and an increase of 7.9 and 10.5% in the Recovery Index for NS and CS groups, respectively. However, for none of these parameters was there a statistically significant change for the HS group ([Fig. 1](#F0001){ref-type="fig"}).

![Intra-group changes in percentage (Δ %) of cardio-respiratory parameters of the three groups.](LJM-10-26680-g001){#F0001}

We observed significant differences in baseline spirometric values when the three groups were compared ([Table 2](#T0002){ref-type="table"}). Smoking cigarettes or hookah resulted in lower values of FEV~1~ and peak expiratory flow (PEF) (*p*\<0.001) compared with the non-smokers, but smoking did not influence the FEV1/FVC ratios (*p*=0.362). By contrast, forced expiratory flow (FEF~50%~) and FEF~25--75%~ values were lower in the smokers compared to the non-smokers (*p*\<0.001 and *p*=0.004, respectively).

###### 

Spirometric data of the three groups before the training protocol

  Parameters            Mean±SD      ANOVA                                                                                            
  --------------------- ------------ ------------------------------------------------ ----------------------------------------------- ------------
  FVC (%)               100.5±5.8    95.5±4.5                                         93.1±7.9[\*\*](#TF0002){ref-type="table-fn"}    *p*=0.018
  FEV~1~ (%)            103.3±5      94.1±6.5[\*\*\*](#TF0002){ref-type="table-fn"}   95.3±6.6[\*\*](#TF0002){ref-type="table-fn"}    *p*\<0.001
  PEF (%)               110.3±5.2    102.5±6.7[\*\*](#TF0002){ref-type="table-fn"}    101±4.3[\*\*\*](#TF0002){ref-type="table-fn"}   *p*\<0.001
  Tiffeneau index (%)   1.03±0.07    0.99±0.06                                        1.03±0.11                                       *p*=0.362
  FEF~25--75%~ (%)      103.3±10.1   94.9±5[\*\*](#TF0002){ref-type="table-fn"}       93.9±4.4[\*\*](#TF0002){ref-type="table-fn"}    *p*=0.004
  FEF~50%~ (%)          99.8±4.5     94.7±2.6[\*\*](#TF0002){ref-type="table-fn"}     93±3.8[\*\*\*](#TF0002){ref-type="table-fn"}    *p*\<0.001

NS: non-smokers; CS: cigarettes smokers; HS: hookah smokers; FVC: forced vital capacity; FEV~1~: forced expiratory volume in 1 second; PEF: peak expiratory flow; FEF~50%~: forced expiratory flow at 50% of FVC; FEF~25--75%~: forced expiratory flow at 25--75% of FVC.

significant difference compared with non-smokers at *p*\<0.01, *p*\<0.001, respectively.

Changes (Δ) in the spirometric values are presented in [Table 3](#T0003){ref-type="table"}. After training, most variables showed a small, positive Δ that did not reach statistical significance. However, significant increases in PEF rate of 3.8 and 3.4% were detected for both CS and HS groups (*p*\<0.01 and *p*\<0.05, respectively), while a significant FEV1 change was observed in the CS group only.

###### 

Improvement rate (Δ) of respiratory parameters in subjects of the three groups (NS, CS, and HS)

  Parameters            Mean±SD      Pre vs. Post                                                                                                                        
  --------------------- ------------ --------------------------------------------- ------------------------------------------- ---- ------------------------------------ -----------------------------------
  FVC (%)               1.9±8.8      4.4±9.6                                       3.6±9                                       ns   ns                                   ns
  FEV~1~ (%)            0.5±7.8      5.8±9.2                                       4±6.4                                       ns   [†](#TF0004){ref-type="table-fn"}    ns
  PEF (%)               −1.4±5.8     3.9±3.8[\*\*](#TF0003){ref-type="table-fn"}   3.4±3.9[\*](#TF0003){ref-type="table-fn"}   ns   [††](#TF0004){ref-type="table-fn"}   [†](#TF0004){ref-type="table-fn"}
  Tiffeneau index (%)   −0.01±0.13   0.02±0.10                                     0.001±0.08                                  ns   ns                                   ns
  FEF~25--75%~ (%)      2.2±4.4      1.8±6.6                                       2.3±5.8                                     ns   ns                                   ns
  FEF~50%~ (%)          0.5±4.1      0.8±3.5                                       0.9±5.2                                     ns   ns                                   ns

NS: non-smokers; CS: cigarettes smokers; HS: hookah smokers; FVC: forced vital capacity; FEV~1~: forced expiratory volume in 1 second; PEF: peak expiratory flow; FEF~50%~: forced expiratory flow at 50% of FVC; FEF~25--75%~: forced expiratory flow at 25--75% of FVC.

significant difference compared with non-smokers at *p*\<0.05, *p*\<0.01, respectively

significant difference pre- vs. postprogram at *p\<*0.05, *p*\<0.01, respectively

As shown in [Fig. 2](#F0002){ref-type="fig"}, a significant increase in FEV~1~ (6.2%) was observed in the SC group (*p*\<0.05). No significant FEV~1~ changes were observed for the other two groups.

![Intra-group changes in percentage (Δ %) of spirometric values of the three groups.](LJM-10-26680-g002){#F0002}

Furthermore, the training program did not result in any significant changes in any of the three groups with respect to FVC and FEF.

Discussion {#S0004}
==========

Physical inactivity and low cardiorespiratory fitness are recognized as important causes of morbidity and mortality ([@CIT0041]--[@CIT0043]). The data presented in this study showed the relation between physical activity in the form of intermittent exercise and cardiorespiratory function for male smokers and non-smokers. In a longitudinal study of Norwegian men ([@CIT0044]), the authors concluded that decline in physical fitness and lung function among healthy middle-aged men was considerably greater among smokers than non-smokers. Smoking is the most important modifiable risk factor for decreased respiratory function ([@CIT0016], [@CIT0045]).

This study was designed to measure the effects of an intermittent training program on lung function and aerobic capacity in adult smokers. Initially, the mean spirometric values of smokers were lower than those of non-smokers. After 12 weeks of training, the mean spirometric values at rest were slightly higher, without a significant difference, except for FEV~1~ and PEF for the CS and HS groups. Pulmonary functions parameters were improved to a greater extent in most participants of the smoker groups than the non-smoker group. The most significant improvements occurred in FEV1 and PEF in the two smoker groups. These results are in line with those of Miles ([@CIT0046]) and Gass et al. ([@CIT0047]). The improvement in PEF was significantly slower among hookah smokers compared to cigarette smokers. In contrast, we did not observe any effect of the 12 weeks of training on FVC or FEF. In the light of these results, we believe that training programs of this duration have only minor effects on spirometric variables.

Our study shows that interval training of more than three times per week reduces the decline in pulmonary function. The beneficial effect of physical activity on pulmonary function was independent of smoking and was almost similar for the two smoking methods.

It has also been claimed that physical activity is positively associated with pulmonary function ([@CIT0013], [@CIT0046], [@CIT0048]) and can enhance inspiratory muscle endurance ([@CIT0049]). Interestingly, using a short-term training protocol, Biersteker et al. ([@CIT0017]) did not observe any effect of physical training on physical fitness and lung vital capacity in young adults.

In the present study, the non-smokers group showed no significant change in lung function as a result of the training program. By contrast, the two groups of smokers saw their respiratory ability improve significantly due to training, a result that is consistent with several previous studies ([@CIT0050], [@CIT0051]). Therefore, this study provides objective data supporting the use of a program of intermittent exercise for strengthening the pulmonary functions of smokers.

A number of benefits of intermittent training have been previously demonstrated. This training program slows the decline in pulmonary function and alleviates symptoms and exacerbation of pulmonary disease, resulting in improvement of quality of life. Our study suggests that interval exercise training may be useful in slowing the progression of pulmonary disease due to cigarette smoking.

It is generally accepted that people with higher levels of physical activity tend to have higher levels of fitness and that physical activity can improve cardiorespiratory fitness ([@CIT0052]). In our study, intermittent exercises were strongly associated with better exercise tolerance assessed with maximal treadmill test, a finding consistent with other studies ([@CIT0042], [@CIT0053]).

In accordance with the literature ([@CIT0054]--[@CIT0057]), our training program produced a significant increase in v $\overset{.}{\text{V}}\text{O}_{2}\text{max}$, $\overset{.}{\text{V}}\text{O}_{2}\text{max}$, and RI for the two smoker groups. Those results are somewhat similar to those reported by Leon et al. ([@CIT0018]), who used the same kind of treadmill test to assess physical capacity of participants. The changes in resting HR, systolic BP, and diastolic BP were also significant. These results demonstrate the efficacy of our intermittent training program in smokers and non-smokers.

In summary, the interval training program used in the present study significantly improved exercise performance and symptoms for both groups of smokers. These conclusions are consistent with the results of several published studies, which indicated that exercise is an important component of pulmonary rehabilitation and may be associated with both physiological and psychological benefits ([@CIT0019]).

Although smoking cessation is certainly an important way to reduce the decline in pulmonary function in smokers, this training method appears to be beneficial in both smokers and non-smokers and can be performed by all individuals. Interval training was related to a slower decline in pulmonary function due to smoking.

Because the exercise intensity was adapted to participant capacity, our intermittent training program is a suitable method for improving ventilatory efficiency. Our findings are potentially important from both the public health and the clinical points of view.

Because passive smoking causes lung function decline, and based on previous findings of Mohammad et al. ([@CIT0058]), we think that future research should include a group of passive smokers. Other studies using other training methods will be needed to advance our conclusions. We believe that the continuous exercise training programs could improve the aerobic capacity and modify more favorably the lung function of smokers.

Conclusions {#S0005}
===========

Our intermittent training program improved the aerobic capacity and modified the cardiorespiratory parameters of smokers in a way that approximates those of non-smokers. After 12 weeks of training, $\overset{.}{\text{V}}\text{O}_{2}\text{max}$ and recovery index were improved, and there was a significant decrease in resting HR. These results demonstrate the beneficial effects of intermittent training on the cardiopulmonary system and quality of life even in the smoking population.
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Limitations of the study {#S0006}
========================

The lack of a control group may be considered a limitation of the present study (smokers following their usual daily activity during the protocol period). Also, the relatively small sample size could have limited our ability to detect group differences in the chosen parameters. This is indeed a limitation of this work, and should be considered relative to our findings.
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